Company Overview of W.L. Gore & Associates, Inc.
W.L. Gore & Associates, Inc. manufactures and sells fluoropolymer products for the electronics industry. It offers consumer products, including outerwear and footwear, bike wear, strings, filters, concealment, and cable systems; cables and cable assemblies, which comprise coaxial, fiber optic, flat, and round cables, as well as hook-up wires, high data rate copper, and microwave/RF cable assemblies; and electronic and electrochemical materials, such as anti-tamper physical security for electronic hardware, dielectric materials, EMI shielding, fuel cell components, battery and capacitors, and diffuse reflector products. The company also provides fabrics and fibers; and filtration products, in...
555 Papermill Road
Newark, DE 19711
Founded in 1958
Key Executives for W.L. Gore & Associates, Inc.
Chief Executive Officer and President
Compensation as of Fiscal Year 2013.
W.L. Gore & Associates, Inc. Key Developments
W.L. Gore & Associates, Inc. Receives Shonin Approval from Japanese Ministry of Health, Labor and Welfare to Market the GORE(R) EXCLUDER(R) AAA Endoprosthesis Featuring C3 Delivery System as Minimally Invasive Treatment for Patients Suffering from Abdominal Aortic Aneurysm
Dec 2 13
W.L. Gore & Associates, Inc. has received Shonin approval from the Japanese Ministry of Health, Labor and Welfare to market the GORE(R) EXCLUDER(R) AAA Endoprosthesis featuring C3 Delivery System as a minimally invasive treatment for patients suffering from an abdominal aortic aneurysm (AAA). The GORE C3 Delivery System enables physicians and interventionalists to reposition the GORE EXCLUDER Device prior to final release from the delivery catheter. The added deployment control provides physicians with increased confidence in treating challenging anatomies, as well as cannulation options with the ability to bring the contralateral gate to the contralateral guidewire. The GORE C3 Delivery System provides physicians with a stent-graft and new delivery system, which was previously unavailable in Japan. The GORE EXCLUDER Device remains virtually unchanged--with the same low delivery profile and flexibility on catheter that facilitates access and passage through narrow and tortuous anatomies. Once delivered into the aorta, the GORE C3 Delivery System intuitively enables repositioning of the stent-graft. The ability to reposition the device may minimize complications that could occur if the stent-graft needs to be repositioned after the initial deployment.
W.L. Gore & Associates, Inc. Announces GORE EXCLUDER Iliac Branch Endoprosthesis Receives CE Mark
Nov 7 13
W. L. Gore & Associates (Gore) announced the GORE EXCLUDER Iliac Branch Endoprosthesis, the first complete, fully engineered system (Gore designed iliac branch and internal iliac components) intended for endovascular treatment of common iliac artery aneurysms or aortoiliac aneurysms, has received CE Mark. The first patient procedures in Europe were successfully completed by vascular surgeons Piergiorgio Cao, MD, Chief of Vascular Surgery at San Camillo Hospital, Rome, Italy, Mo Hamady, MD, Consultant Interventional Radiologist at St. Mary's Hospital, London, and Mr. Michael Jenkins, Consultant Vascular Surgeon and Clinical Lead at St. Mary's Hospital, London. This new device, used in conjunction with GORE EXCLUDER AAA Endoprosthesis components to isolate the common iliac artery from systemic blood flow and preserve blood flow in the external iliac and internal iliac arteries, is built on Gore's proven technology platform and designed using the same durable, expanded polytetrafluoroethylene (ePTFE) graft. The GORE EXCLUDER Iliac Branch Endoprosthesis system provides a treatment range of 6.5-13.5 mm for the internal iliac arteries, and a treatment range of 6.5-25 mm for the external iliac arteries. The delivery profile of the loaded catheter allows the use of a 16 Fr introducer sheath for the iliac branch component, and a 12 Fr flexible, reinforced introducer sheath for the internal iliac component. The GORE EXCLUDER Iliac Branch Endoprosthesis is part of the growing family of GORE EXCLUDER Device products that share a mission to effectively treat aortic aneurysms through minimally invasive means, backed by Gore's highly rated clinical support team and comprehensive educational offerings.
W. L. Gore & Associates (Gore) Receives United States Food and Drug Administration Approval for 25 Cm Gore(R) Viabahn(R) Endoprosthesis
Nov 6 13
W. L. Gore & Associates (Gore) announced that the US Food and Drug Administration (FDA) has approved the 25 cm GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface for the treatment of symptomatic peripheral arterial disease lesions in the Superficial Femoral Artery (SFA). The new 25 cm endoprosthesis is the longest length stent-graft available, and is designed to cover long-segment lesions in the SFA, potentially reducing the need for multiple devices. The FDA approval of the 25 cm device was supported by evidence from a multicenter European trial. Patients enrolled in the study had lesion lengths ranging from 20 cm to 40 cm, with a mean length of 26.5 cm. Of all patients enrolled, 92.9% had total occlusions of the SFA. One-year data demonstrated a freedom from target lesion revascularization of 78.2%. In addition, the GORE VIABAHN Device exhibited no fractures at 12 months.
Similar Private Companies By Industry
Recent Private Companies Transactions